Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Roche Aktiebolag
AB
Active
Org 5560383100
Arvid Tydéns Allé 7, 171 69
Solna
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1939 · 87 years old
71 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Roche Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
1.7B
1.3B
0.8B
0.4B
0B
2020: 1.2B
1.2B
2020
2021: 1.1B (-11% vs 2020)
1.1B
-11%
2021
2022: 1.1B (+1% vs 2021)
1.1B
+1%
2022
2023: 1.2B (+8% vs 2022)
1.2B
+8%
2023
2024: 1.3B (+12% vs 2023)
1.3B
+12%
2024
EBITDA
SEK millions
74M
22M
-31M
-83M
-135M
2020: -1M
-1M
2020
2021: -17M (-1600% vs 2020)
-17M
-1600%
2021
2022: -94M (-453% vs 2021)
-94M
-453%
2022
2023: 33M (+135% vs 2022)
33M
+135%
2023
2024: 33M (0% vs 2023)
33M
0%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
1 347 947
1 200 434
1 112 248
1 100 861
1 233 439
Staff expenses
—
—
—
—
—
EBITDA
33 070
33 159
−93 937
−16 973
−1 426
Depreciation & amort.
−1 411
−1 402
−1 430
−1 681
−1 845
EBIT
31 659
31 757
−95 367
−18 654
−3 271
Net financials
26 297
−2 160
131 162
38 682
39 738
Profit before tax
57 956
29 597
35 796
20 028
36 468
Tax
−12 860
−6 641
−7 891
−4 685
−8 448
Net profit
45 096
22 956
27 905
15 343
28 020
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
635 544
581 948
421 883
543 881
512 236
Equity
256 734
213 281
190 325
162 421
147 078
Long-term debt
0
0
0
0
0
Short-term debt
378 810
366 274
219 186
377 215
351 519
Total debt
378 810
366 274
219 186
377 215
351 519
Financial ratios
5-year trend
EBITDA margin
2,5 %
This company
15,8 %
Market median
This company
Market median
84% below market
2020
2024
Equity ratio
40,4 %
This company
38,2 %
Market median
This company
Market median
6% above market
2020
2024
Return on equity
17,6 %
This company
18,4 %
Market median
This company
Market median
4% below market
2020
2024
Net profit margin
3,3 %
This company
8,1 %
Market median
This company
Market median
59% below market
2020
2024
Asset turnover
2,12×
This company
1,12×
Market median
This company
Market median
89% above market
2020
2024
Debt / equity
1,48×
This company
0,62×
Market median
This company
Market median
139% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Roche Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
